E160: Anesthesia Market Update with LocumTene...

Thinking about locums but unsure where to start? Tanner sits down with Gavin and Chase, CRNAs and co-founders of Krewe Anesthesia, to break down what locums really looks like—myths, red flags, lifestyle flexibility, credentialing, and how to find assignments that actually fit you ...  Show more

Perioperative antibiotics are part of nearly every anesthetic — but how often do we stop to ask why a specific antibiotic was chosen? In this episode, Cole and Tanner break down perioperative antibiotic prophylaxis from an anesthesia perspective, including selection, timing, comm ...  Show more

Lipid Drugs: Part 1

Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N

Host: Stephen L. Kopecky, M.D.

In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available ...

Ozempic. Developed as diabetes medication. Adopted as a weight loss drug. Eyed for its potential neuroprotective effects.

Hollywood's popularization of Ozempic as a way to lose weight has made it one of the most widely-discussed drugs of our time, an ...

In this episode, hosts Drs. Peter Lu and Jason Silverman talk to Dr. Rima Fawaz about the role of GLP-1 receptor ...

In this episode, Dr. K breaks down the hype around dopamine detoxes and social media breaks—and why they don’t actually solve the problem. Drawing on his background in addiction psychiatry, he explains that detoxing only pauses the cycle temporarily; if you go back to the same ha ...  Show more